Liu Jessica J, Bell Chaim M, Matelski John J, Detsky Allan S, Cram Peter
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Department of Medicine, Division of General Internal Medicine, University Health Network and Sinai Health System, Toronto, Ontario, Canada.
BMJ. 2017 Oct 26;359:j4619. doi: 10.1136/bmj.j4619.
To estimate financial payments from industry to US journal editors. Retrospective observational study. 52 influential (high impact factor for their specialty) US medical journals from 26 specialties and US Open Payments database, 2014. 713 editors at the associate level and above identified from each journal's online masthead. All general payments (eg, personal income) and research related payments from pharmaceutical and medical device manufacturers to eligible physicians in 2014. Percentages of editors receiving payments and the magnitude of such payments were compared across journals and by specialty. Journal websites were also reviewed to determine if conflict of interest policies for editors were readily accessible. Of 713 eligible editors, 361 (50.6%) received some (>$0) general payments in 2014, and 139 (19.5%) received research payments. The median general payment was $11 (£8; €9) (interquartile range $0-2923) and the median research payment was $0 ($0-0). The mean general payment was $28 136 (SD $415 045), and the mean research payment was $37 963 (SD $175 239). The highest median general payments were received by journal editors from endocrinology ($7207, $0-85 816), cardiology ($2664, $0-12 912), gastroenterology ($696, $0-20 002), rheumatology ($515, $0-14 280), and urology ($480, $90-669). For high impact general medicine journals, median payments were $0 ($0-14). A review of the 52 journal websites revealed that editor conflict of interest policies were readily accessible (ie, within five minutes) for 17/52 (32.7%) of journals. Industry payments to journal editors are common and often large, particularly for certain subspecialties. Journals should consider the potential impact of such payments on public trust in published research.
评估美国行业向期刊编辑支付的费用。回顾性观察研究。来自26个专业的52种有影响力的（其专业领域影响因子高）美国医学期刊以及2014年美国公开支付数据库。从每种期刊的在线刊头中识别出713名副主编及以上级别的编辑。2014年制药和医疗器械制造商向符合条件的医生支付的所有一般费用（如个人收入）以及与研究相关的费用。比较各期刊之间以及按专业划分的接受支付的编辑百分比和此类支付的金额。还对期刊网站进行了审查，以确定编辑的利益冲突政策是否易于获取。在713名符合条件的编辑中，361名（50.6%）在2014年收到了一些（>0美元）一般费用，139名（19.5%）收到了研究费用。一般费用的中位数为11美元（8英镑；9欧元）（四分位距0 - 2923美元），研究费用的中位数为0美元（0 - 0美元）。一般费用的均值为28136美元（标准差415045美元），研究费用的均值为37963美元（标准差175239美元）。内分泌学领域的期刊编辑收到的一般费用中位数最高（7207美元，0 - 85816美元），其次是心脏病学（2664美元，0 - 12912美元）、胃肠病学（696美元，0 - 20002美元）、风湿病学（515美元，0 - 14280美元）和泌尿学（480美元，90 - 669美元）。对于高影响力的综合医学期刊，费用中位数为0美元（0 - 14美元）。对52个期刊网站的审查显示，17/52（32.7%）的期刊编辑利益冲突政策易于获取（即五分钟内可找到）。行业向期刊编辑支付费用很常见，且数额往往较大，尤其是在某些亚专业领域。期刊应考虑此类支付对公众对已发表研究的信任可能产生的影响。
